Skip to main content
Fig. 3 | Experimental Hematology & Oncology

Fig. 3

From: Targeting phosphoglycerate dehydrogenase in multiple myeloma

Fig. 3

PHGDH knockdown potentiates bortezomib and proteasome-resistant cell lines are sensitive to PHGDH inhibition. a The knockdown of PHGDH using shRNA was confirmed via WB. b CTG was used to highlight the dependence of the shPHGDH cells on extracellular serine. The sensitivity to drugs was tested by CTG. c, d INA6 KD cells were treated overnight with carfilzomib and bortezomib, respectively. e, f INA6-res and AMO1-res cell lines, respectively, were treated with the indicated doses of NCT-503 overnight. All the presented graphs and calculated IC50s represent three independent experiments with minimum two replicates. Error bars are ± SEM and *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001

Back to article page